Cardiovascular Drugs and Therapy

ISSNs: 0920-3206, 1573-7241

Kluwer Academic

Scopus rating (2023): CiteScore 8.3 SJR 0.973 SNIP 0.814

Journal

Titles	Cardiovascular Drugs and Therapy Cardiovascular drugs and therapy
Additional searchable titles	Cardiovascular drugs and therapy, Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy, Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy.
ISSNs	0920-3206, 1573-7241
Publisher	Kluwer Academic
ZDB-ID	639068-7
ZDB-ID	2003553-6

Keywords

ASJC Scopus subject areas

Pharmacology
Cardiology and Cardiovascular Medicine
Pharmacology (medical)

Library keywords

610 Medicine and health

Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study

Laufs, U., Birkenfeld, A. L., Fraass, U., Hohenstein, B., Siegert, C., Klotsche, J., Steinhagen-Thiessen, E., & 6 othersPittrow, D., Dexl, S., Salmen, S., Schettler, V. J. J., Parhofer, K. G. & Study, C. I. T. PERI-DYS., 2022, In: Cardiovascular Drugs and Therapy.

Research output: Contribution to journal › Research article › Contributed › peer-review

Absence of Functional Na_v1.8 Channels in Non-diseased Atrial and Ventricular Cardiomyocytes

Casini, S., Marchal, G. A., Kawasaki, M., Nariswari, F. A., Portero, V., van den Berg, N. W. E., Guan, K., & 6 othersDriessen, A. H. G., Veldkamp, M. W., Mengarelli, I., de Groot, J. R., Verkerk, A. O. & Remme, C. A., 1 Dec 2019, In: Cardiovascular drugs and therapy. 33, 6, p. 649-660 12 p.